infohep news

• Coronavirus

  COVID-19 in chronic liver disease: advanced cirrhosis greatly raises risk of death

  Keith Alcorn / 22 May 2020

  People with chronic liver disease admitted to hospital with COVID-19 are dying at a much higher rate than the rest of the population, figures collated by liver specialists in Europe, Asia and ...

• Weight gain after hepatitis C cure is common

  Keith Alcorn / 19 May 2020

  Substantial weight gain is common after hepatitis C cure, an analysis of a large cohort shows, and around one in five people with normal body weight became overweight within two years, US ...

• NAFLD

  Non-alcoholic fatty liver disease affects a quarter of lean people living with HIV

  Michael Carter / 13 May 2020

  A quarter of people living with HIV with normal body weight have non-alcoholic-fatty liver disease (NAFLD), Italian and Canadian investigators report in Clinical Infectious Diseases. Risk factors were older age, ...

• Treatment in acute infection

  Short-course treatment for recent hepatitis C: some courses may be too short

  Keith Alcorn / 07 May 2020

  An eight-week course of grazoprevir/pibrentasvir (Zepatier) achieved a high cure rate in people recently infected with hepatitis C, but another study found that a six-week course of sofosbuvir/velpatasvir (Epclusa) resulted in an inferior ...

• Treatment for people living with HIV and HCV

  Hepatitis C treatment in adolescents and young people late but successful, Spanish study shows

  Keith Alcorn / 05 May 2020

  Treatment for hepatitis C was highly effective in clearing the virus in young people coinfected with HIV and hepatitis C through vertical infection, despite advanced fibrosis in one-third, Spanish researchers report in the ...